AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27768727 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mM supplemental alanyl-glutamine (AlaGln) added to glucose-based PD fluid
Number of subjects: 20
Study 27768727 — intervention group
Group type: COMPARATOR
Intervention: Conventional acidic, single chamber 3.86% glucose PD fluid without AlaGln
Number of subjects: 20
Study 25031188 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose thiazide diuretics (12.5 mg/day of hydrochlorothiazide)
Number of subjects: 1130
Study 25031188 — intervention group
Group type: COMPARATOR
Intervention: No thiazide diuretics
Number of subjects: 1130
Study 23147291 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human bone morphogenetic protein-2 (rhBMP-2) with resorbable collagen sponge
Number of subjects: 18
Study 23147291 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous iliac crest bone grafting
Number of subjects: 18
Study 23147291 — intervention group
Group type: COMPARATOR
Intervention: Periosteoplasty
Number of subjects: 18
Study 20127616 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency rTMS (10 Hz, 10 sessions, 10,000 stimuli over 2 weeks)
Number of subjects: 32
Study 20127616 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 32
Study 18570306 — intervention group
Group type: EXPERIMENTAL
Intervention: DUAL 1500 (1500 mg R1626 bid + peginterferon alfa‐2a)
Number of subjects: 104
Study 18570306 — intervention group
Group type: EXPERIMENTAL
Intervention: DUAL 3000 (3000 mg R1626 bid + peginterferon alfa‐2a)
Number of subjects: 104
Study 18570306 — intervention group
Group type: EXPERIMENTAL
Intervention: TRIPLE 1500 (1500 mg R1626 bid + peginterferon alfa‐2a + ribavirin)
Number of subjects: 104
Study 18570306 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC: peginterferon alfa‐2a + ribavirin)
Number of subjects: 104
Study 16029797 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 Gy fraction (total dose 15.0 Gy)
Number of subjects: 290
Study 16029797 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.0 Gy fraction (total dose 30.0 Gy)
Number of subjects: 290
Study 16029797 — intervention group
Group type: COMPARATOR
Intervention: Overall locoregional recurrence rate
Number of subjects: 290
Study 11925390 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyrotrophin-releasing hormone (TRH) infusion
Number of subjects: 21
Study 11925390 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopaminergic type 2 (DA2) receptor blockade
Number of subjects: 21
Study 11925390 — intervention group
Group type: COMPARATOR
Intervention: Comparison with fertile patients without endometriosis
Number of subjects: 21
Study 10521386 — intervention group
Group type: EXPERIMENTAL
Intervention: gemfibrozil
Number of subjects: 52
Study 10521386 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids
Number of subjects: 52
Study 9150976 — intervention group
Group type: EXPERIMENTAL
Intervention: Pallesthesiometry (vibration sensitivity threshold measurement)
Number of subjects: 0
Study 2205571 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylocaine (1 mg/kg iv)
Number of subjects: 30
Study 7430412 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin estolate capsules
Number of subjects: 16
Study 7430412 — intervention group
Group type: COMPARATOR
Intervention: Enteric-coated erythromycin base tablets
Number of subjects: 16
Study 31164360 — intervention group
Group type: EXPERIMENTAL
Intervention: Loaded self-managed exercise intervention including education and advice on physical activity
Number of subjects: 20
Study 31164360 — intervention group
Group type: COMPARATOR
Intervention: Usual physiotherapy
Number of subjects: 20
Study 28232972 — intervention group
Group type: EXPERIMENTAL
Intervention: Staged toothbrush (Candida Parodin)
Number of subjects: 35
Study 28232972 — intervention group
Group type: EXPERIMENTAL
Intervention: V-shaped toothbrush (Oral-B Ortho)
Number of subjects: 35
Study 28232972 — intervention group
Group type: COMPARATOR
Intervention: Planar control brushes (Paro M 43)
Number of subjects: 35
Study 26005776 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (20mg/day)
Number of subjects: 46
Study 26005776 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin (20mg/day)
Number of subjects: 46
Study 23942231 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 9
Study 23942231 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-focused therapy
Number of subjects: 9
Study 23942231 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation
Number of subjects: 9
Study 23942231 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced relapse prevention
Number of subjects: 9
Study 23942231 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver group psychoeducation
Number of subjects: 9
Study 23942231 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief technique-driven interventions
Number of subjects: 9
Study 23942231 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (specific study)
Number of subjects: 9
Study 23942231 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced relapse prevention (specific study)
Number of subjects: 9
Study 23942231 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief technique-driven interventions (specific study)
Number of subjects: 9
Study 21336838 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO mouth rinse (25 ml)
Number of subjects: 12
Study 21336838 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA) mouth rinse
Number of subjects: 12
Study 21336838 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 12
Study 21336838 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO mouth rinse
Number of subjects: 12
Study 21336838 — intervention group
Group type: EXPERIMENTAL
Intervention: Both tests (1-RM and strength endurance)
Number of subjects: 12
Study 19058194 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous training
Number of subjects: 0
Study 19058194 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval training
Number of subjects: 0
Study 17192510 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovator 0.005% latanoprost ophthalmic solution
Number of subjects: 0
Study 17192510 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclodextrin-containing latanoprost ophthalmic solution
Number of subjects: 0
Study 17192510 — intervention group
Group type: COMPARATOR
Intervention: Both formulations
Number of subjects: 0
Study 15149259 — intervention group
Group type: EXPERIMENTAL
Intervention: Intergroup competition (combination of competition and cooperation)
Number of subjects: 0
Study 15149259 — intervention group
Group type: COMPARATOR
Intervention: Competition
Number of subjects: 0
Study 15149259 — intervention group
Group type: COMPARATOR
Intervention: Cooperation
Number of subjects: 0
Study 11464717 — intervention group
Group type: EXPERIMENTAL
Intervention: TNF-alpha levels in sera of ALS patients
Number of subjects: 15
Study 11464717 — intervention group
Group type: EXPERIMENTAL
Intervention: CD2, CD4, CD8 markers on mononuclear cells
Number of subjects: 15
Study 9727375 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE I/D and PstI genotypes in patients with overt proteinuria or chronic renal failure (127 patients)
Number of subjects: 941
Study 9727375 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE I/D and PstI genotypes in patients with microalbuminuria (335 patients)
Number of subjects: 941
Study 9727375 — intervention group
Group type: COMPARATOR
Intervention: ACE I/D and PstI genotypes in normoalbuminuric patients (254 patients)
Number of subjects: 941
Study 7979809 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryopreservation-thawing of sperm from patients with teratozoospermia
Number of subjects: 27
Study 7979809 — intervention group
Group type: COMPARATOR
Intervention: Cryopreservation-thawing of sperm from fertile donors
Number of subjects: 27
Study 7979809 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen-thawed-washed specimens
Number of subjects: 27
Study 7979809 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh sperm samples from patients
Number of subjects: 27
Study 7979809 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh sperm samples from donors
Number of subjects: 27
Study 7979809 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple regression analysis for patient group
Number of subjects: 27
Study 2730278 — intervention group
Group type: EXPERIMENTAL
Intervention: m-chlorophenylpiperazine (mCPP) administered intravenously
Number of subjects: 22
Study 31559634 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 155 U every 12 weeks for 3 cycles
Number of subjects: 282
Study 31559634 — intervention group
Group type: COMPARATOR
Intervention: Topiramate 50-100 mg/day to week 36
Number of subjects: 282
Study 31559634 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA
Number of subjects: 282
Study 31559634 — intervention group
Group type: COMPARATOR
Intervention: Topiramate
Number of subjects: 282
Study 28703838 — intervention group
Group type: EXPERIMENTAL
Intervention: Revifast® with DCI/MI
Number of subjects: 110
Study 28703838 — intervention group
Group type: EXPERIMENTAL
Intervention: DCI/MI alone
Number of subjects: 110
Study 28703838 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 110
Study 25344375 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfacalcidol (1 mcg/d, N=80)
Number of subjects: 158
Study 25344375 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N=78)
Number of subjects: 158
Study 25344375 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfacalcidol
Number of subjects: 158
Study 25226738 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural honey (70 g daily for 4 weeks)
Number of subjects: 70
Study 25226738 — intervention group
Group type: COMPARATOR
Intervention: Control group (same diet without honey)
Number of subjects: 70
Study 20934312 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (Hcort)
Number of subjects: 20
Study 18817597 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised treatment (10 mg amodiaquine/kg and 4 mg artesunate/kg daily for 3 days, directly observed in hospital)
Number of subjects: 308
Study 18817597 — intervention group
Group type: COMPARATOR
Intervention: Unsupervised treatment (first dose supervised, remaining doses taken at home)
Number of subjects: 308
Study 16839800 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention with manipulation
Number of subjects: 131
Study 16839800 — intervention group
Group type: COMPARATOR
Intervention: Exercise intervention without manipulation
Number of subjects: 131
Study 12870136 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive surveillance strategy (periodic clinical examinations, laboratory tests, radiographic imaging, CEA testing)
Number of subjects: 0
Study 12870136 — intervention group
Group type: COMPARATOR
Intervention: Less frequent testing
Number of subjects: 0
Study 10747828 — intervention group
Group type: EXPERIMENTAL
Intervention: trovafloxacin 200 mg od
Number of subjects: 48
Study 10747828 — intervention group
Group type: EXPERIMENTAL
Intervention: ciprofloxacin 500 mg bd
Number of subjects: 48
Study 10747828 — intervention group
Group type: EXPERIMENTAL
Intervention: lomefloxacin 400 mg od
Number of subjects: 48
Study 8694169 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ibuprofen
Number of subjects: 10
Study 8694169 — intervention group
Group type: COMPARATOR
Intervention: EMLA cream
Number of subjects: 10
Study 8694169 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 1893812 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil 80 mg orally every 6 hr for 10 doses
Number of subjects: 10
Study 1893812 — intervention group
Group type: EXPERIMENTAL
Intervention: diltiazem 60 mg by mouth as one dose
Number of subjects: 10
Study 1893812 — intervention group
Group type: COMPARATOR
Intervention: no premedication
Number of subjects: 10
Study 7065521 — intervention group
Group type: EXPERIMENTAL
Intervention: High serum concentration of theophylline (20 mg/L)
Number of subjects: 20
Study 7065521 — intervention group
Group type: COMPARATOR
Intervention: Low serum concentration of theophylline (10 mg/L)
Number of subjects: 20
Study 31249362 — intervention group
Group type: EXPERIMENTAL
Intervention: FLG loss-of-function mutations
Number of subjects: 712
Study 28353600 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum-chewing (sugarless gum, 3 times daily for at least 15 minutes until postoperative exhaust defecation)
Number of subjects: 75
Study 28353600 — intervention group
Group type: COMPARATOR
Intervention: Control (No gum)
Number of subjects: 75
Study 26535950 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Check-Up intervention
Number of subjects: 731
Study 26535950 — intervention group
Group type: COMPARATOR
Intervention: Women, Infants, and Children as usual
Number of subjects: 731
Study 23789741 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance training
Number of subjects: 48
Study 23789741 — intervention group
Group type: COMPARATOR
Intervention: Usual-care control
Number of subjects: 48
Study 21184653 — intervention group
Group type: EXPERIMENTAL
Intervention: Levocetirizine
Number of subjects: 40
Study 21184653 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 19656025 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth ultrasonic debridement + amoxicillin and metronidazole
Number of subjects: 25
Study 19656025 — intervention group
Group type: COMPARATOR
Intervention: Full-mouth ultrasonic debridement + placebo
Number of subjects: 25
Study 18042574 — intervention group
Group type: EXPERIMENTAL
Intervention: Low vision rehabilitation program
Number of subjects: 126
Study 18042574 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 126
Study 14739186 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant follicle stimulating hormone
Number of subjects: 168
Study 14739186 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrocautery followed by clomiphene citrate and recombinant follicle stimulating hormone
Number of subjects: 168
Study 14739186 — intervention group
Group type: COMPARATOR
Intervention: Electrocautery
Number of subjects: 168
Study 11152843 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak exercise systolic blood pressure < or =140 mm Hg
Number of subjects: 625
Study 11152843 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program participation
Number of subjects: 625
Study 9129894 — intervention group
Group type: EXPERIMENTAL
Intervention: 15,000 IU of heparin (group A)
Number of subjects: 400
Study 9129894 — intervention group
Group type: COMPARATOR
Intervention: 100 IU.kg‐1 of heparin (group B)
Number of subjects: 400
Study 7961027 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermoradiotherapy (HTRT) with regional hyperthermia and radiotherapy, total dose ranged from 42 to 80 Gy (mean 62.9 Gy) for definitive treatment, and 38 to 47 Gy (mean 40.6 Gy) for preoperative cases. Radiofrequency capacitive hyperthermia was administered twice weekly, with total sessions ranging from 5 to 16 (mean 9.0) for definitive treatment and 3 to 8 (mean 6.7) for preoperative cases.
Number of subjects: 19
Study 7961027 — intervention group
Group type: COMPARATOR
Intervention: Control group (RT) with historical data, initially unresectable Stage III NSCLC irradiated definitively with 50 Gy or more (26 cases), or became resectable after radiotherapy and operated (4 cases).
Number of subjects: 19
Study 2885365 — intervention group
Group type: EXPERIMENTAL
Intervention: Astemizole
Number of subjects: 0
Study 2885365 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpheniramine
Number of subjects: 0
Study 2885365 — intervention group
Group type: EXPERIMENTAL
Intervention: Astemizole + Alcohol
Number of subjects: 0
Study 2885365 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpheniramine + Alcohol
Number of subjects: 0
Study 2885365 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 0
Study 31959233 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise programme for 12 weeks
Number of subjects: 51
Study 31959233 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle physical activity group (LPAG) aiming to increase daily physical activity and reduce sedentary behaviour for 12 weeks
Number of subjects: 51
Study 31959233 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 51
Study 31959233 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise programme
Number of subjects: 51
Study 31959233 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle physical activity group (LPAG)
Number of subjects: 51
Study 29358714 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram treatment in AD model mice
Number of subjects: 0
Study 29358714 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram treatment in SH-SY5Y human neuronal cells
Number of subjects: 0
Study 29358714 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram treatment in alcohol-dependent patients
Number of subjects: 0
Study 27741244 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message support program
Number of subjects: 710
Study 24572041 — intervention group
Group type: EXPERIMENTAL
Intervention: Lupin kernel fiber (LF) 25-g/d
Number of subjects: 60
Study 21923659 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fluence high repetition rate 810 nm diode laser
Number of subjects: 49
Study 21923659 — intervention group
Group type: COMPARATOR
Intervention: High fluence low repetition rate 1064 nm Nd:YAG laser
Number of subjects: 49
Study 20107202 — intervention group
Group type: EXPERIMENTAL
Intervention: LRPT 50 mg
Number of subjects: 0
Study 20107202 — intervention group
Group type: EXPERIMENTAL
Intervention: LRPT 600 mg
Number of subjects: 0
Study 20107202 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20107202 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg
Number of subjects: 0
Study 17352635 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser therapy (7 joules/2 min) over the carpal tunnel area, 41 patients
Number of subjects: 81
Study 17352635 — intervention group
Group type: COMPARATOR
Intervention: Placebo laser therapy, 40 patients
Number of subjects: 81
Study 15142298 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional Stroop task with asthma symptom words
Number of subjects: 3
Study 15142298 — intervention group
Group type: COMPARATOR
Intervention: Emotional Stroop task with general negative words
Number of subjects: 3
Study 15142298 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported adherence levels
Number of subjects: 3
Study 11524195 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine 0.5%
Number of subjects: 36
Study 11524195 — intervention group
Group type: COMPARATOR
Intervention: Rimexolone 1%
Number of subjects: 36
Study 9810742 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental design (e.g. randomized clinical trial)
Number of subjects: 0
Study 9810742 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-experimental designs (case series analysis, cohort and case control studies)
Number of subjects: 0
Study 7824087 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (3.5 mg/kg bolus injection)
Number of subjects: 22
Study 7824087 — intervention group
Group type: COMPARATOR
Intervention: Standard meal
Number of subjects: 22
Study 3277488 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate ointment (100 mg tid)
Number of subjects: 30
Study 3277488 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 29925328 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin oral solution (5 mg/kg in 5 ml strawberry juice)
Number of subjects: 70
Study 29925328 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5 ml of oral strawberry juice)
Number of subjects: 70
Study 29231406 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral position group
Number of subjects: 76
Study 29231406 — intervention group
Group type: COMPARATOR
Intervention: Prone position group
Number of subjects: 76
Study 24527598 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic taping for 5 days with therapeutic stretch
Number of subjects: 0
Study 24527598 — intervention group
Group type: COMPARATOR
Intervention: Placebo taping without therapeutic stretch
Number of subjects: 0
Study 23536312 — intervention group
Group type: EXPERIMENTAL
Intervention: True suprasensory stimulation
Number of subjects: 11
Study 23536312 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 11
Study 20223573 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine HCl with 1:100,000 epinephrine
Number of subjects: 30
Study 20223573 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine HCl with 1:200,000 epinephrine
Number of subjects: 30
Study 18768528 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous bortezomib (1.3 mg/m2, days 1, 4, 8, 11; eight 21‐day cycles)
Number of subjects: 24
Study 18768528 — intervention group
Group type: COMPARATOR
Intervention: Intravenous bortezomib (1.3 mg/m2, days 1, 4, 8, 11; eight 21‐day cycles)
Number of subjects: 24
Study 16864147 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/day for 6 months
Number of subjects: 40
Study 15298978 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 3 transfer
Number of subjects: 460
Study 15298978 — intervention group
Group type: COMPARATOR
Intervention: Day 5 transfer
Number of subjects: 460
Study 11930704 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled Beclomethasone dipropionate (BDP) 200 micrograms/d
Number of subjects: 30
Study 11930704 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled Beclomethasone dipropionate (BDP) 400 micrograms/d
Number of subjects: 30
Study 11930704 — intervention group
Group type: COMPARATOR
Intervention: Inhaled placebo
Number of subjects: 30
Study 9773137 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalaprilat 30 micrograms.kg-1
Number of subjects: 38
Study 9773137 — intervention group
Group type: COMPARATOR
Intervention: NaCl 0.9% (Control)
Number of subjects: 38
Study 7880660 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal hyoscine
Number of subjects: 60
Study 7880660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 3345619 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg alprazolam plus saline infusion
Number of subjects: 4
Study 3345619 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 mg alprazolam plus saline
Number of subjects: 4